Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director departure
Alaunos Therapeutics, Inc. (ZIOP) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/28/2023 8-K Quarterly results
08/14/2023 8-K Quarterly results
Docs: "Alaunos Therapeutics Announces Second Quarter 2023 Financial Results, Interim Clinical Data and Exploration of Strategic Alternatives"
07/05/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
06/12/2023 8-K Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea...
Docs: "Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Alaunos Therapeutics, Inc.",
"Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Alaunos Therapeutics, Inc."
05/10/2023 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Alaunos Therapeutics Reports First Quarter 2023 Financial Results"
04/04/2023 8-K Entry into a Material Definitive Agreement  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
04/03/2023 8-K Entry into a Material Definitive Agreement  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
03/30/2023 8-K Quarterly results
03/07/2023 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Alaunos Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results"
01/09/2023 8-K Quarterly results
01/04/2023 8-K Quarterly results
11/30/2022 8-K Quarterly results
11/14/2022 8-K Quarterly results
11/07/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Alaunos Therapeutics to Present Data Highlighting its hunTR ™ TCR Discovery Platform at the Society for Immunotherapy of Cancer 2022 Annual Meeting"
09/30/2022 8-K Quarterly results
09/21/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Alaunos Therapeutics Highlights Data from TCR-T Library Phase 1/2 Trial at the CRI-ENCI-AACR Sixth International Cancer Immunotherapy Conference"
09/06/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Alaunos Therapeutics Announces Early Clinical Data Showing Objective Clinical Response Using its TCR-T Cell Therapy"
08/24/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Alaunos Therapeutics to Present at the CRI-ENCI-AACR Sixth International Cancer Immunotherapy Conference"
08/15/2022 8-K Quarterly results
08/04/2022 8-K Quarterly results
07/13/2022 8-K Quarterly results
06/27/2022 8-K Quarterly results
06/17/2022 8-K Quarterly results
05/24/2022 8-K Quarterly results
05/16/2022 8-K Quarterly results
05/02/2022 8-K Quarterly results
05/02/2022 8-K Quarterly results
03/30/2022 8-K Quarterly results
Docs: "Alaunos Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results"
03/18/2022 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
03/17/2022 8-K Investor presentation
Docs: "Presentation, dated March 2022",
"Presentation, dated March 2022"
01/26/2022 8-K Investor presentation
Docs: "Certificate of Amendment",
"Presentation, dated January 2022",
"Ziopharm Oncology Highlights Operational Progress & Rebrands to Alaunos Therapeutics"
01/04/2022 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
11/05/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
10/01/2021 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy